Your session is about to expire
← Back to Search
In-Home Technology for Dementia Caregivers
N/A
Recruiting
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months to 6 months
Awards & highlights
Study Summary
This trial is testing a new technology to help support caregivers of people with Alzheimer's Disease or other forms of dementia. The hope is that this will help reduce the burden, anxiety, and loneliness that these caregivers often feel.
Who is the study for?
This trial is for English-speaking caregivers who use smartphones and live in rural US areas with a spouse or family member diagnosed with Alzheimer's, other dementias, or mild cognitive impairment.Check my eligibility
What is being tested?
The study is testing two levels of in-home technology designed to help reduce anxiety, burden, and loneliness for caregivers of individuals with dementia-related conditions living in rural homes.See study design
What are the potential side effects?
Since this trial involves the use of in-home technology systems rather than medications, traditional side effects are not applicable. However, there may be potential issues such as increased stress due to technological challenges.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from 3 Months to 6 Months in Beck Anxiety Inventory (BAI)
Change from 3 Months to 6 Months in Center for Epidemiological Studies Depression Scale (CES-D)
Change from 3 Months to 6 Months in Revised Functional Limitations Battery
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: In-Home Technology SystemExperimental Treatment1 Intervention
The full system [(a) 1 advanced gateway with a dual-SIM cellular connection to communicate/control the equipment; (b) 5 indoor motion sensors; (c) 3 door/cabinet entry sensors; (d) 1 water leak sensor; (e) 1 "call for help" button; (f) 2 motion-activated LED night lights; (g) 2 Vayyar fall detection and sleep quality sensors] will be self-installed by rural caregivers (N=60) in their homes. Monitoring of sensors, provision of warnings, messaging, and social networking features will be activated remotely for those participants who have been randomly assigned to this arm. Participation will extend over a 6 month period with questionnaires (e.g., health and well-being) administered 3 times (at the time of installation and every 3 months thereafter).
Group II: Limited In-Home Technology SystemPlacebo Group1 Intervention
The full system [(a) 1 advanced gateway with a dual-SIM cellular connection to communicate/control the equipment; (b) 5 indoor motion sensors; (c) 3 door/cabinet entry sensors; (d) 1 water leak sensor; (e) 1 "call for help" button; (f) 2 motion-activated LED night lights; (g) 2 Vayyar fall detection and sleep quality sensors] will be self-installed by rural caregivers (N=60) in their homes. Only monitoring of the water leak sensor and associated warnings will be activated remotely for those participants who have been randomly assigned to this arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
In-Home Technology System
2022
N/A
~10
Find a Location
Who is running the clinical trial?
People Power CompanyIndustry Sponsor
4 Previous Clinical Trials
422 Total Patients Enrolled
4 Trials studying Dementia
422 Patients Enrolled for Dementia
University of California, San FranciscoOTHER
2,505 Previous Clinical Trials
15,237,435 Total Patients Enrolled
34 Trials studying Dementia
203,666 Patients Enrolled for Dementia
University of California, BerkeleyLead Sponsor
181 Previous Clinical Trials
721,036 Total Patients Enrolled
4 Trials studying Dementia
422 Patients Enrolled for Dementia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this study actively seeking participants?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial, which was first advertised on the 1st of September 2022, is currently recruiting individuals for participation. The study aims to sign up 120 participants from a single medical institute."
Answered by AI
How many participants is the research team recruiting for this trial?
"Affirmative. Records on clinicaltrials.gov show that this clinical trial, which was first shared on September 1st 2022, is still open for recruitment. The study requires 120 individuals to be recruited from a single location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger